CRISPR Therapeutics (NASDAQ:CRSP) Given New $47.00 Price Target at The Goldman Sachs Group
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target lowered by equities research analysts at The Goldman Sachs Group from $53.00 to $47.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s target price suggests a potential upside of 31.95% […]
More Stories
Is 1670 Season 3 Renewed? Release Date, Cast, and Episodes
The troublemaker Jan Pawel Adamczewski is returning with more silliness, conflicts, and uprisings in 1670, Season 3. This is a...
Know about Disney’s Hexed: Release Date and Trailer
The teaser for the upcoming Disney film, Hexed, is out. Want to know more? Keep reading. Fawn Veerasunthorn, the creator...
Restaurant Fit-Out Planning Tips for Comfort, Flow and Durability
A restaurant fit-out is really juggling two jobs at the same time. It has to make guests feel like they’ve...
How to Choose the Perfect Dining Table for Your Home Layout
A dining table ends up being more than a table, doesn’t it. Meals happen there, sure, but that’s barely the...
What is Snapchat Planet Order? Meaning, Origin, and More Details
Snapchat is one of the most widely used social media platforms. It stands neck to neck with other popular social...
Is The Amazing Digital Circus Renewed? Know about its Release Date
Are you also a fan of adult anime shows? Good news, everyone’s favourite fantasy drama, The Amazing Digital Circus, aka...